Jun 25, 2021· Comment from American Pharmacists Association (APhA)· FDA-2020-N-1862-0028
Please see the attached comments of the American Pharmacists Association (APhA). APhA supports efforts to protect the integrity of our nation's drug supply and appreciates the opportunity to submit these comments and maintain a dialogue with FDA on important DSCSA issues. The fast-approaching November 2023 implementation deadline and the significant work that must go into building compliant systems and processes, testing and troubleshooting, and education and training necessitates that FDA and trading partners focus solely on the core requirements of the DSCSA.